The global pneumonia testing market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.
Pneumonia is an infection in the lower respiratory tract caused by bacteria, viruses and fungi. It spreads via the inhalation of airborne droplets from the sneeze or cough of an infected person. It leads to inflammation in the air sacs of the lungs and shortness of breath. It also reduces appetite and causes mild fever, dry cough, headaches, fatigue, chills and chest pain. It is diagnosed through pneumonia testing, which includes a physical examination, medical history review, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample.
Pneumonia Testing Market Trends:
At present, there is a rise in the utilization of point of care (POC) testing to detect pneumonia on account of its higher efficiency and rapid and accurate test results. This, along with the burgeoning healthcare industry, represents one of the key factors driving the market. Moreover, the introduction of immunochromatographic, pneumococcal urinary antigen (UAT) and advanced nucleic acid detection tests is propelling the growth of the market. In addition, the growing awareness among individuals about the benefits of early diagnosis is augmenting the number of pneumonia testing across the globe. This, coupled with the rising healthcare expenditure by governments of several countries, is contributing to the growth of the market. Besides this, there is an increase in the adoption of enzyme-linked immunosorbent assay (ELISA) to detect pneumonia as it is highly sensitive and easier to carry out. Other growth-inducing factors are the growing geriatric population and rising prevalence of pneumonia among children around the world. Furthermore, key market players are focusing on new product launches and approvals which is projected to bolster the growth of the market.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market,Request Sample
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pneumonia testingmarket report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, method, technology and end user.
Breakup by Type:
Analyzers
Consumables
Breakup by Method:
Immunodiagnostics
Molecular Diagnostics
Point of Care Testing
Breakup by Technology:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market,Request Sample
Enzyme-linked Immunosorbent Assay
Immunofluorescence
Western Blot
Polymerase Chain Reaction
Immunohistochemistry
Others
Breakup by End User:
Hospitals
Diagnostic Laboratories
Homecare
Others
Breakup by Region:
To get more information on the regional analysis of this market,Request Sample
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Report Coverage:
Report Features
Details
Base Year of the Analysis
2022
Historical Period
2017-2022
Forecast Period
2023-2028
Units
US$ Billion
Segment Coverage
Type, Method, Technology, End User, Region
Region Covered
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered
Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Customization Scope
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
10-12 Weeks
Delivery Format
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global pneumonia testing market was valued at US$ 1.6 Billion in 2022.
We expect the global pneumonia testing market to exhibit a CAGR of 7.4% during 2023-2028.
The rising utilization of Point of Care (POC) testing to detect pneumonia, owing to its higher efficiency and rapid and accurate test results, along with the growing consumer awareness regarding the benefits of early diagnosis for pneumonia, is primarily driving the global pneumonia testing market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of pneumonia testing for treating the coronavirus-infected patients associated with pneumonia symptoms.
Based on the type, the global pneumonia testing market has been divided into analyzers and consumables, where analyzers currently exhibit a clear dominance in the market.
Based on the method, the global pneumonia testing market can be categorized into immunodiagnostics, molecular diagnostics, and point of care testing. Currently, point of care testing accounts for the majority of the global market share.
Based on the technology, the global pneumonia testing market has been segregated into enzyme-linked immunosorbent assay, immunofluorescence, western blot, polymerase chain reaction, immunohistochemistry, and others. Among these, enzyme-linked immunosorbent assay currently holds the largest market share.
Based on the end user, the global pneumonia testing market can be bifurcated into hospitals, diagnostic laboratories, homecare, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global pneumonia testing market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.